We are live on ! Find out more
KCM

Knoll Capital Management Portfolio holdings

AUM $180M
1-Year Est. Return 66.11%
This Fund
S&P 500
This Quarter Est. Return
+12.86%
1 Year Est. Return
+66.11%
3 Year Est. Return
+268.55%
5 Year Est. Return
+741%
10 Year Est. Return
+10,877.35%
AUM
$175M
AUM Growth
+$15.9M
Cap. Flow
+$4.28M
Cap. Flow %
2.44%
Top 10 Hldgs %
89.06%
Holding
43
New
2
Increased
7
Reduced
1
Closed
2

Top Buys

Rank Stock Value
1
ALDX icon
Aldeyra Therapeutics
ALDX
+$2.56M
2
WPM icon
Wheaton Precious Metals
WPM
+$716K
3
OR icon
OR Royalties Inc
OR
+$540K
4
SILV
SilverCrest Metals Inc. Common Shares
SILV
+$394K
5
EQX icon
Equinox Gold
EQX
+$346K

Top Sells

Rank Stock Value
1
AVXL icon
Anavex Life Sciences
AVXL
+$2.6M
2
AG icon
First Majestic Silver
AG
+$434K
3
MAG
MAG Silver
MAG
+$65.1K

Sector Composition

Rank Sector Weight
1 Healthcare 87.45%
2 Materials 4%
3 Technology 1.92%
4 Financials 1.38%
5 Industrials 1.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BHVN
1
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$131M 75%
900,844
– –
ALDX icon
2
Aldeyra Therapeutics
ALDX
$91.7M
$6M 3.42%
1,502,460
+743,055
+98% +$2.56M
EIGR
3
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
$4.37M 2.5%
23,141
– –
ENTX icon
4
Entera Bio
ENTX
$101M
$3.3M 1.89%
2,484,275
– –
ALT icon
5
Altimmune
ALT
$539M
$1.56M 0.89%
132,978
– –
BX icon
6
Blackstone
BX
$104B
$1.46M 0.83%
16,000
– –
CVS icon
7
CVS Health
CVS
$137B
$1.34M 0.77%
14,500
– –
ANET icon
8
Arista Networks
ANET
$219B
$1.29M 0.74%
55,200
– –
CRBP icon
9
Corbus Pharmaceuticals
CRBP
$170M
$1.27M 0.73%
168,196
– –
BAH icon
10
Booz Allen Hamilton
BAH
$8.7B
$1.18M 0.67%
13,000
– –
TMO icon
11
Thermo Fisher Scientific
TMO
$211B
$1.14M 0.65%
2,100
– –
LUMN icon
12
Lumen
LUMN
$6.53B
$1.09M 0.62%
100,000
– –
APLT
13
DELISTED
Applied Therapeutics
APLT
$1.03M 0.59%
1,082,123
– –
EQX icon
14
Equinox Gold
EQX
$7.32B
$971K 0.55%
99,000
+53,500
+118% +$346K
V icon
15
Visa
V
$677B
$955K 0.55%
4,850
– –
MO icon
16
Altria Group
MO
$122B
$948K 0.54%
22,700
– –
SILV
17
DELISTED
SilverCrest Metals Inc. Common Shares
SILV
$861K 0.49%
100,000
+52,000
+108% +$394K
PAAS icon
18
Pan American Silver
PAAS
$18.6B
$849K 0.48%
29,500
+13,200
+81% +$316K
GLW icon
19
Corning
GLW
$126B
$838K 0.48%
26,600
– –
MMX
20
DELISTED
Maverix Metals Inc. Common Shares
MMX
$718K 0.41%
165,000
+50,000
+43% +$227K
AEM icon
21
Agnico Eagle Mines
AEM
$72.6B
$704K 0.4%
15,393
– –
OSK icon
22
Oshkosh
OSK
$9.67B
$694K 0.4%
8,450
– –
OR icon
23
OR Royalties Inc
OR
$5.47B
$676K 0.39%
235,000
+45,000
+24% +$540K
FNV icon
24
Franco-Nevada
FNV
$41.4B
$645K 0.37%
4,900
+1,150
+31% +$170K
AMD icon
25
Advanced Micro Devices
AMD
$851B
$627K 0.36%
8,200
– –
1
2

Similar funds

MGWA
Monument Group Wealth Advisors Concord, Massachusetts $180M AUM 19.81% 1-Year Est. Return
AW
Alchemi Wealth Essex, Connecticut $180M AUM
FBC
Fairfield, Bush & Co Darien, Connecticut $180M AUM 39.51% 1-Year Est. Return
AIC
Aurora Investment Counsel Atlanta, Georgia $180M AUM 0.3% 1-Year Est. Return
AG
Amiral Gestion Paris, France $180M AUM 9.43% 1-Year Est. Return
PCA
Prospect Capital Advisors Sausalito, California $180M AUM 60.99% 1-Year Est. Return
HIC
Hamrick Investment Counsel Seattle, Washington $180M AUM
FFA
Frazier Financial Advisors Columbus, Ohio $181M AUM 11.16% 1-Year Est. Return

Knoll Capital Management's Q2 2022 Portfolio in Review

As of Q2 2022, Knoll Capital Management held 43 positions worth $175M, up 10% from $159M the previous quarter. Its ten largest holdings account for 89% of the portfolio.

Knoll Capital Management's Q2 2022 filing shows 2 new, 7 increased, 1 reduced and 2 closed positions. Its largest new stake was Wheaton Precious Metals: 16,500 shares worth $594K. The largest sale was Anavex Life Sciences, an estimated $2.6M.

By sector, the portfolio is most concentrated in Healthcare at 87% of assets, up from 86% a quarter earlier, followed by Materials and Technology.

  • Knoll Capital Management's largest Q2 2022 buy was Wheaton Precious Metals: 16,500 shares worth $594K.
  • Knoll Capital Management added most to Aldeyra Therapeutics in Q2 2022, an estimated $2.56M increase.
  • Knoll Capital Management's biggest Q2 2022 reduction was MAG Silver, cutting an estimated $65.1K.
  • Knoll Capital Management fully exited Anavex Life Sciences in Q2 2022, selling an estimated $2.6M.
  • Knoll Capital Management's ten largest holdings make up 89% of its $175M portfolio in Q2 2022.
  • Knoll Capital Management opened 2 new positions and closed 2 in Q2 2022.
  • Knoll Capital Management's portfolio value rose 10% quarter-over-quarter to $175M.

Based on Knoll Capital Management's 13F filing for Q2 2022, filed 15 Aug 2022.